CLINICAL_TRIALS
trial_result
· 2023-07-19
Clinical Trial Update: A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases [Phase 2]
Summary
Phase 2 multicenter trial evaluating riociguat in patients with sickle cell disease has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mark Gladwin | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-07-19